๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

UP-03.111 TIN Therapy as Salvage Chemotherapy for Cisplatin Refractory Germ Cell Tumors

โœ Scribed by Nakamura, T.; Mikami, K.; Kimura, Y.; Hongo, F.; Takaha, N.; Miki, T.

Book ID
122687788
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
80 KB
Volume
78
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of ifosfamide plus cisplatin-ba
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
โœ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete

Irinotecan plus cisplatin has substantia
Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors
โœ Tsuneharu Miki; Yoichi Mizutani; Norio Nonomura; Takeshi Nomoto; Masahiro Nakao; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

## Background: Only 20-30% of patients with refractory or recurrent germ cell tumors (gct) are cured by salvage chemotherapy. irinotecan, a new derivative of camptothecin, is a potent anticancer agent against a variety of solid cancers. the current pilot study investigated the efficacy of salvage c